Quest Diagnostics Incorporated (DGX) vs Mettler-Toledo International, Inc. (MTD)

Quest Diagnostics Incorporated and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Mettler-Toledo International, Inc. is the larger, with a market value of $33.6B against $28.0B — 1.2× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 37.6×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.13% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 9.50%) and the higher return on invested capital (35.4% vs 8.48%). Across the 22 metrics below, Quest Diagnostics Incorporated leads on 13 and Mettler-Toledo International, Inc. on 9.

Valuation

Metric DGX MTD Diagnostics & Research median
P/E 24.98 37.65 34.52
P/S 2.36 8.16 4.24
P/B 3.52 2,631.36 3.42
Price to free cash flow 20.34 39.06 33.51
EV/EBITDA 14.18 27.43 23.44
EV/Sales 2.76 8.66 5.18
Earnings yield 4.00% 2.66% (1.50%)
Free cash flow yield 4.92% 2.56% 0.00%

Profitability

Metric DGX MTD Diagnostics & Research median
Gross margin 33.11% 60.26% 48.32%
Operating margin 14.55% 28.41% (5.68%)
Net margin 9.50% 21.91% (4.10%)
Free cash flow margin 11.61% 20.90% 0.00%
Return on equity 14.76% (736.36%) 0.00%
Return on assets 6.73% 25.61% (6.05%)
Return on invested capital 8.48% 35.40% 0.00%

Growth

Metric DGX MTD Diagnostics & Research median
Revenue growth (TTM) 9.13% 6.91% 8.99%
EPS growth (last fiscal year) 13.78% 3.88% 20.36%
Revenue growth, 5-year CAGR 3.18% 5.47% 7.30%
Net income growth, 5-year CAGR (7.06%) 7.60% 0.00%

Health

Metric DGX MTD Diagnostics & Research median
Debt to equity 0.70 164.70 0.01
Current ratio 1.70 1.12 2.27
Net debt to EBITDA 2.47 1.68 0.68

Dividend

Metric DGX MTD Diagnostics & Research median
Dividend yield 1.33% — 0.67%
Payout ratio 0.34 — 0.20

Size

Metric DGX MTD Diagnostics & Research median
Market cap 28.03b 33.64b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack